Fahri Saatcioglu

Bilde av Fahri Saatcioglu
English version of this page
Telefon +47-22854569
Rom 3611
Brukernavn
Besøksadresse Blindernveien 31 0371 OSLO
Postadresse Postboks 1066 Blindern 0316 OSLO
Andre tilknytninger Institutt for biovitenskap

Research Interests

The goal of the studies in our laboratory is to understand how androgens, male sex hormones, exert their effects on the normal physiology, as well as their role in disease states. Androgens bind to an intracellular receptor, called the androgen receptor (AR), that belongs to a superfamily of ligand-activated transcription factors, called nuclear receptors, which bring about changes in the phenotype of the cell through modulation of gene expression. To understand this process, we are using molecular, biochemical, cell biological and genetic approaches. Since androgens and AR have a significant role in prostate cancer, this work is also relevant for identification and validation of biomarkers or therapeutic targets for prostate cancer.


Teaching

MBV 3020 Genetics and developmental biology
MBV 3090 Research literature in cancer biology


Academic appointments

1/2013-Present       Professor, Dept. of Biosciences, University of Oslo
1/2002-12/2012      Professor, Dept. of Molecular Biosciences, University of Oslo
10/2000-Present     Visiting Scientist, Harvard School of Public Health, Boston, USA
02/2011-Present     Researcher (20%), Institute for Medical Informatics, Division of Surgery and Cancer Medicine, Oslo University Hospital, Oslo, Norway
11/2009-08/2010    Sabbatical, Harvard School of Public Health, Boston, USA
10/2000-11/2001    Sabbatical, Harvard School of Public Health, Boston, USA
7/1996-12/2001      Group Leader, Biotechnology Centre of Oslo, University of Oslo
10/1993-4/1996      Assistant Research Molecular Biologist, Department of Pharmacology, School of Medicine, University of California, San Diego, CA, USA
9/1990-9/1993        Post-doctoral fellow, Department of Pharmacology, School of Medicine, University of California, San Diego, CA, USA
3/1990-7/1990        Visiting scientist, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA


Honors and distinctions

2009-2012      Special Cancer Program Award, Norwegian Research Council
2004-2007      Top Researcher Award, Norwegian Research Council
2004-2007       Special Cancer Program Award, Norwegian Research Council
2001-2003      Top Researcher Award, Norwegian Research Council
2000-2003      Special Cancer Program Award, Norwegian Research Council
1995-1996      ACS Institutional Fellowship, University of California, San Diego
1994-1995      Research Committee Award, University of California, San Diego
1993-1995       New Investigator Award, AIDS Related Disease Research Program, University of California
1992-1993       Post-doctoral fellowship, American Heart Association
1990-1992       Post-doctoral fellowship, Tobacco Related Disease Research Program, University of California
1987, 89, 90    Visiting Scientist Fellowship, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (3-12 weeks at a time)
1987, 7-11       Visiting Researcher, Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD
1985                Salutatorian of the graduating class


Committees

Ad hoc grant review committees: Cancer Research UK; Prostate Cancer Charity UK; Australia Research Council; European Research Council. Member, Senior Editorial Board, American J. of Cancer Research, 2010-2013. Ad hoc reviewer for several international refereed journals, including Nature Reviews Cancer, Cancer Research, Clinical Cancer Research, Oncogene, J. of Pathology, Int. J. of Cancer, J. of Urology, Neoplasia, Tumor Biology, BMC Molecular Biology, Endocrine Related Cancer, Thrombosis and Haemostasis. Director, PhD Program, IMBV, University of Oslo, 2006-present. Advisor to eight PhD and 15 MSc students who have successfully completed their degrees, trained 6 postdoctoral fellows. Currently advisor for 3 PhD and 3 MSc students, and 2 postdoctoral fellows.

 

Current collaborations

University of Oslo
Oslo University Hospital
Cancer Registry of Norway
Umeå University, Sweden
Gothenborg University, Sweden
Lund University, Sweden
University of Porto, Portugal
Harvard University, USA
National Institutes of Health, USA
MD Andersen Cancer Center, USA
Vancouver Prostate Cancer, Canada

 

Publikasjoner

  • Jin, Yang; Nenseth, Hatice Zeynep & Saatcioglu, Fahri (2017). Role of PLZF as a tumor suppressor in prostate cancer. OncoTarget.  ISSN 1949-2553.  8(41), s 71317- 71324 . doi: 10.18632/oncotarget.19813
  • Urbanucci, Alfonso; Barfeld, Stefan Jörg; Kytölä, Ville; Itkonen, Harri; Coleman, Ilsa M.; Vodák, Daniel; Sjöblom, Liisa; Sheng, Xia; Minner, Sarah; Burdelski, Christoph; Kivinummi, Kati K.; Kohvakka, Annika; Kregel, Steven; Takhar, Mandeep; Alshalalfa, Mohammed; Davicioni, Elai; Erho, Nicholas; Lloyd, Paul; Karnes, R. Jeffrey; Ross, Ashley E.; Schaeffer, Edward M.; Vander Griend, Donald J; Knapp, Stefan; Corey, Eva; Feng, Felix Y.; Nelson, Peter S.; Saatcioglu, Fahri; Knudsen, Karen E.; Tammela, Teuvo L.J.; Sauter, Guido; Schlomm, Thorsten; Nykter, Matti; Visakorpi, Tapio & Mills, Ian Geoffrey (2017). Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer. Cell reports.  ISSN 2211-1247.  19(10), s 2045- 2059 . doi: 10.1016/j.celrep.2017.05.049
  • Lindstad, Torstein; Qu, Su; Sikkeland, Jørgen; Jin, Yang; Kristian, Alexandr; Mælandsmo, Gunhild; Collas, Philippe & Saatcioglu, Fahri (2016). STAMP2 is required for human adipose-derived stem cell differentiation and adiposite-facilitated prostrate cancer grown in vivo.. OncoTarget.  ISSN 1949-2553. . doi: 10.18632/oncotarget.11131
  • Sikkeland, Jørgen; Sheng, Xia; Jin, Yang & Saatcioglu, Fahri (2016). STAMPing at the crossroads of normal physiology and disease states. Molecular and Cellular Endocrinology.  ISSN 0303-7207.  425, s 26- 36 . doi: 10.1016/j.mce.2016.02.013
  • Storm, Margrethe Larsdatter; Sheng, Xia; Arnoldussen, Yke Jildouw & Saatcioglu, Fahri (2016). Prostate cancer and the unfolded protein response. OncoTarget.  ISSN 1949-2553.  7(33), s 54051- 54066 . doi: 10.18632/oncotarget.9912 Fulltekst i vitenarkiv.
  • Tesikova, Martina; Dezitter, Xavier Gabriel M; Nenseth, Hatice Zeynep; Klokk, Tove Irene; Mueller, Florian; Hager, Gordon L. & Saatcioglu, Fahri (2016). Divergent binding and transactivation by two related steroid receptors at the same response element. Journal of Biological Chemistry.  ISSN 0021-9258.  291(22), s 11899- 11910 . doi: 10.1074/jbc.M115.684480
  • Ertunc, Meric Erikci; Sikkeland, Jørgen; Fenaroli, Federico; Griffiths, Gareth Wyn; Daniels, Melissa C.; Cao, Haiming; Saatcioglu, Fahri & Hotamisligil, Gökhan S. (2015). Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity. Journal of Lipid Research.  ISSN 0022-2275.  56(2), s 423- 434 . doi: 10.1194/jlr.M055798
  • Jin, Yang; Ling, Wang; Qu, Su; Sheng, Xia; Kristian, Alexandr; Mælandsmo, Gunhild; Pällmann, Nora; Yuca, Erkan; Tekedereli, Ibrahim; Gorgulu, Kivanc; Alpay, Neslihan; Sood, Anil K.; Lopez-Berestein, Gabriel; Fazli, Ladan; Rennie, Paul S.; Risberg, Bjørn Åke; Wæhre, Haakon; Danielsen, Håvard Emil; Ozpolat, Bulent & Saatcioglu, Fahri (2015). STAMP2 increases oxidative stress and is critical for prostate cancer. EMBO Molecular Medicine.  ISSN 1757-4676.  7(3), s 315- 331 . doi: 10.15252/emmm.201404181 Fulltekst i vitenarkiv.
  • Sheng, Xia; Arnoldussen, Yke Jildouw; Storm, Margrethe Larsdatter; Tesikova, Martina; Nenseth, Hatice Zeynep; Zhao, Sen; Fazli, Ladan; Rennie, Paul S.; Risberg, Bjørn Åke; Wæhre, Haakon; Danielsen, Håvard Emil; Mills, Ian Geoffrey; Jin, Yang; Hotamisligil, Gökhan S & Saatcioglu, Fahri (2015). Divergent androgen regulation of unfolded protein response pathways drives prostate cancer. EMBO Molecular Medicine.  ISSN 1757-4676.  7(6), s 788- 801 . doi: 10.15252/emmm.201404509 Fulltekst i vitenarkiv.
  • Nenseth, Hatice Zeynep; Dezitter, Xavier; Tesikova, Martina; Mueller, Florian; Klokk, Tove Irene; Hager, Gordon L. & Saatcioglu, Fahri (2014). Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells. PLoS ONE.  ISSN 1932-6203.  9(8) . doi: 10.1371/journal.pone.0105204 Fulltekst i vitenarkiv.
  • Sikkeland, Jørgen; Jin, Yang & Saatcioglu, Fahri (2014). Methods to assess lipid accumulation in cancer cells. Methods in Enzymology.  ISSN 0076-6879.  542, s 407- 423 . doi: 10.1016/B978-0-12-416618-9.00021-2
  • Jin, Yang; Qu, Su; Tesikova, Martina; Ling, Wang; Kristian, Alexandr; Mælandsmo, Gunhild; Kong, Haiying; Zhang, Tianzhou; Jerónimo, Carmen; Teixeira, Manuel; Yuca, Erkan; Tekedereli, Ibrahim; Gorgulu, Kivanc; Alpay, Nelihan; Sood, Anil K.; Lopez-Berestein, Gabriel; Danielsen, Håvard Emil; Ozpolat, Bulent & Saatcioglu, Fahri (2013). Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America.  ISSN 0027-8424.  110(28), s E2572- E2581 . doi: 10.1073/pnas.1304318110
  • Kaarbø, Mari; Storm, Margrethe; Qu, Su; Wæhre, Haakon; Risberg, Bjørn Åke; Danielsen, Håvard Emil & Saatcioglu, Fahri (2013). TCTP is an androgen-regulated gene implicated in prostate cancer. PLoS ONE.  ISSN 1932-6203.  8(7:e69398) . doi: 10.1371/journal.pone.0069398 Fulltekst i vitenarkiv.
  • Qu, Su; Olafsrud, Solveig Mjelstad; Meza-Zepeda, Leonardo Andrés & Saatcioglu, Fahri (2013). Rapid Gene Expression Changes in Peripheral Blood Lymphocytes upon Practice of a Comprehensive Yoga Program. PLoS ONE.  ISSN 1932-6203.  8(4) . doi: 10.1371/journal.pone.0061910
  • Sikkeland, Jørgen & Saatcioglu, Fahri (2013). Differential Expression and Function of Stamp Family Proteins in Adipocyte Differentiation. PLoS ONE.  ISSN 1932-6203.  8(7) . doi: 10.1371/journal.pone.0068249 Fulltekst i vitenarkiv.
  • Lazarevic, Bato; Hammarstrøm, Clara Louise; Yang, Jing; Ramberg, Håkon Andre; Diep, Lien My; Karlsen, Steinar; Kucuk, O; Saatcioglu, Fahri; Tasken, Kristin Austlid & Svindland, Aud (2012). The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. British Journal of Nutrition.  ISSN 0007-1145.  108(12), s 2138- 2147 . doi: 10.1017/S0007114512000384
  • ten Freyhaus, Henrik; Calay, Ediz S; Yalcin, Abdullah; Vallerie, Sara N; Yang, Ling; Calay, Zerrin Z; Saatcioglu, Fahri & Hotamisligil, Gökhan S (2012). Stamp2 Controls Macrophage Inflammation through Nicotinamide Adenine Dinucleotide Phosphate Homeostasis and Protects against Atherosclerosis. Cell Metabolism.  ISSN 1550-4131.  16(1), s 81- 89 . doi: 10.1016/j.cmet.2012.05.009
  • Lazarevic, Bato; Boezelijn, Gro; Diep, Lien My; Kvernrød, Kristin; Øgren, Hans Olov; Ramberg, Håkon Andre; Moen, Anders; Wessel, Nicolai; Berg, Rolf Eigil; Jacobsen, Wolfgang Mathias; Hammarstrøm, Clara Louise; Svindland, Aud; Kucuk, Omer; Saatcioglu, Fahri; Tasken, Kristin Austlid & Karlsen, Steinar (2011). Efficacy and Safety of Short-Term Genistein Intervention in Patients with Localized Prostate Cancer Prior to Radical Prostatectomy: A Randomized, Placebo-Controlled, Double-Blind Phase 2 Clinical Trial. Nutrition and Cancer.  ISSN 0163-5581.  63(6), s 889- 898 . doi: 10.1080/01635581.2011.582221
  • Varisli, Lokman; Gonen-Korkmaz, Ceren; Debelec-Butuner, Bilge; Erbaykent-Tepedelen, Burcu; Muhammed, Hamed Sayed; Bogurcu, Nuray; Saatcioglu, Fahri & Korkmaz, Kemal (2011). Ubiquitously Expressed Hematological and Neurological Expressed 1 Downregulates Akt-Mediated GSK3 beta Signaling, and Its Knockdown Results in Deregulated G2/M Transition in Prostate Cells. DNA and Cell Biology.  ISSN 1044-5498.  30(6), s 419- 429 . doi: 10.1089/dna.2010.1128
  • Kaarbø, Mari; Mikkelsen, Øyvind Løveseter; Malerød, Lene; Qu, Su; Lobert, Viola; Akgul, Gulcan; Halvorsen, Thomas; Mælandsmo, Gunhild M & Saatcioglu, Fahri (2010). PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Cellular Oncology.  ISSN 1570-5870.  32(1-2), s 11- 27 . doi: 10.3233/CLO-2009-0487
  • Lindstad, Torstein; Jin, Yang; Ling, Wang; Qu, Su & Saatcioglu, Fahri (2010). STAMPs at the Crossroads of Cancer and Nutrition. Nutrition and Cancer.  ISSN 0163-5581.  62(7), s 891- 895 . doi: 10.1080/01635581.2010.509836
  • Ling, Wang; Jin, Yang; Arnoldussen, Yke Jildouw; Jonson, Ida; Qu, Su; Mælandsmo, Gunhild; Kristian, Alexandr; Risberg, Bjørn; Wæhre, Haakon; Danielsen, Håvard Emil & Saatcioglu, Fahri (2010). STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer. Cancer Research.  ISSN 0008-5472.  70(14), s 5818- 5828 . doi: 10.1158/0008-5472.CAN-09-4697
  • Arnoldussen, Yke Jildouw & Saatcioglu, Fahri (2009). Dual specificity phosphatases in prostate cancer. Molecular and Cellular Endocrinology.  ISSN 0303-7207.  309(1-2), s 1- 7 . doi: 10.1016/j.mce.2009.05.019
  • Arnoldussen, Yke Jildouw; Lorenzo, Petra Isabel O.; Einarsen, Maria; Wæhre, Haakon; Risberg, Bjørn; Mælandsmo, Gunhild M; Danielsen, Håvard Emil & Saatcioglu, Fahri (2008). The Mitogen-Activated Protein Kinase Phosphatase Vaccinia H1-Related Protein Inhibits Apoptosis in Prostate Cancer Cells and Is Overexpressed in Prostate Cancer. Cancer Research.  ISSN 0008-5472.  68(22), s 9255- 9264 . doi: 10.1158/0008-5472.CAN-08-1224
  • Fladeby, Cathrine; Nigam, Shailly; Gupta, Shailly N.; Barois, Nicolas; Lorenzo, Petri; Simpson, Jeremy C.; Saatcioglu, Fahri & Bakke, Oddmund (2008). Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells. International Journal of Cancer.  ISSN 0020-7136.  122(6), s 1229- 1235 . doi: 10.1002/ijc.23185
  • Lazarevic, Bato; Karlsen, Steinar & Saatcioglu, Fahri (2008). Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells. Oncology Reports.  ISSN 1021-335X.  19, s 1231- 1235
  • Lorenzo, Petra Isabel O. & Saatcioglu, Fahri (2008). Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation. Neoplasia.  ISSN 1522-8002.  10, s 418- 428 . doi: 10.1593/neo.07985
  • Davidson, B; Xi, Zhijun & Saatcioglu, Fahri (2007). Kallikrein 4 is expressed in malignant mesotheliorna-further evidence for the histogenetic link between mesothelial and epithelial cells. Diagnostic Cytopathology.  ISSN 8755-1039.  35 . doi: 10.1002/dc.20588
  • Irer, SV; Alper, GE; Sezer, ED; Duman, E; Saatcioglu, Fahri & Yilmaz, C (2007). The effect of l-deprenyl on tissue mRNA expressions of NOS isoforms and NO levels in an experimental diabetes mellitus model. Journal of neural transmission.  ISSN 0300-9564.  114 . doi: 10.1007/s00702-007-0693-9
  • Kaarbø, Mari; Klokk, Tove Irene & Saatcioglu, Fahri (2007). Androgen signaling and its interaction with other signaling pathways in prostate cancer. Bioessays.  ISSN 0265-9247.  29, s 1227- 1238 . doi: 10.1002/bies.20676
  • kjellgren, a; bood, sa; Axelsson, K; Norlander, T & Saatcioglu, Fahri (2007). Wellness through a comprehensive Yogic breathing program - A controlled pilot trial. BMC Complementary and Alternative Medicine.  ISSN 1472-6882.  7(1), s 43
  • Klokk, Tove Irene; Kilander, Anette; Xi, Zhijun; Wæhre, Haakon; Risberg, Bjørn; Danielsen, Håvard Emil & Saatcioglu, Fahri (2007). Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Research.  ISSN 0008-5472.  67, s 5221- 5230 . doi: 10.1158/0008-5472.CAN-06-4728
  • Klokk, Tove Irene; Kurys, Piotr Jerzy; Elbi, C; Nagaich, AK; Hendarwanto, A; Slagsvold, Thomas; Chang, CY; Hager, GL & Saatcioglu, Fahri (2007). Ligand-specific dynamics of the androgen receptor at its response element in living cells. Molecular and Cellular Biology.  ISSN 0270-7306.  27 . doi: 10.1128/MCB.01297-06
  • Wellen, KE; Fucho, R; Gregor, MF; Furuhashi, M; Morgan, C; Lindstad, Torstein; Vaillancourt, E; Gorgun, CZ; Saatcioglu, Fahri & Hotamisligil, GS (2007). Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell.  ISSN 0092-8674.  129 . doi: 10.1016/j.cell.2007.02.049
  • Aslan, G; Irer, B; Tuna, B; Yorukoglu, K; Saatcioglu, Fahri & Celebi, I (2006). analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Pathology, Research and Practice.  ISSN 0344-0338.  202(2), s 93- 98
  • Davidson, Ben; Xi, Zhijun; Klokk, Tove Irene; Tropé, Claes Gøran; Dorum, Anne; Scheistroen, M & Saatcioglu, Fahri (2005). Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. American Journal of Clinical Pathology.  ISSN 0002-9173.  123(3), s 360- 368
  • Korkmaz, Ceren; Korkmaz, Kemal; Kurys, Piotr Jerzy; Elbi, Cem; Ling, Wang; Klokk, Tove Irene; Hammarstrom, C; Trøen, G; Svindland, Aud; Hager, G. & Saatcioglu, Fahri (2005). Molecular cloning and characterization of STAMP2, an andogen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene.  ISSN 0950-9232.  24(31), s 4934- 45
  • Lind, Gruo Elisabeth; Skotheim, Rolf Inge; Fraga, Mario F; Abeler, Vera Maria; Henrique, Rui; Saatcioglu, Fahri; Manel, Esteller; Teixeira, Manuel R & Lothe, Ragnhild A (2005). The loss of NKX3.1 expression in testicular - and prostate - cancers is not caused by promoter hypermethylation. Molecular Cancer.  ISSN 1476-4598.  4(1), s 8 . doi: 10.1186/1476-4598-4-8
  • Fronsdal, K & Saatcioglu, Fahri (2005). Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. The Prostate.  ISSN 0270-4137.  62
  • Frønsdal, K. & Saatcioglu, Fahri (2005). Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. The Prostate.  ISSN 0270-4137.  62(3), s 299- 306
  • Frønsdal, Katrine & Saatcioglu, Fahri (2005). Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. The Prostate.  ISSN 0270-4137.  62(3), s 299- 306
  • Lorenzo, Petra Isabel O. & Saatcioglu, Fahri (2004). Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants. Journal of Endocrinology.  ISSN 0022-0795.  182, s 377
  • Korkmaz, Ceren; Korkmaz, Kemal; Manola, Judith; Xi, Zhijun; Risberg, Bjørn; Danielsen, Håvard Emil; Kung, Janet; Sellsers, William R; Loda, Massimo & Saatcioglu, Fahri (2004). Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. Journal of Urology.  ISSN 0022-5347.  172, s 1134- 1139
  • Xi, Zhijun; Klokk, Tove Irene; Korkmaz, Kemal; Kurys, Piotr Jerzy; Elbi, C; Risberg, Bjørn; Danielsen, Håvard Emil; Loda, M & Saatcioglu, Fahri (2004). Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Research.  ISSN 0008-5472.  64(7), s 2365- 2370
  • Xi, Zhijun; Kærn, Janne; Davidson, Ben; Klokk, Tove Irene; Risberg, Bjørn; Tropé, Claes Gøran & Saatcioglu, Fahri (2004). Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer. Gynecologic Oncology.  ISSN 0090-8258.  94, s 80- 85 . doi: 10.1016/j.ygyno.2004.03.044
  • Bratland, Åse; Ragnhildstveit, Erlend; Bjørnland, Kristin; Andersen, Kristin; Mælandsmo, Gunhild Mari; Fodstad, Øystein; Saatcioglu, Fahri & Ree, Anne Hansen (2003). The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. Clinical and Experimental Metastasis.  ISSN 0262-0898.  20(6), s 541- 547
  • Skotheim, Rolf Inge; Korkmaz, Kemal; Klokk, Tove Irene; Abeler, Vera M; Korlmaz, CG; Nesland, Jahn M; Fosså, Sophie Dorothea; Lothe, Ragnhild A & Saatcioglu, Fahri (2003). NKX3.1 expression is lost in testicular germ cell tumors. American Journal of Pathology.  ISSN 0002-9440.  163(6), s 2149- 2154
  • Berghagen, H.; Krogsrud, K.; Ragnhildstveit, Erlend; Thuestad, Gunnar; Aprilletti, J. & Saatcioglu, Fahri (2002). Corepressor SMRT Functions as a Coactivator for Thyroid Hormone Receptor T3Ralpha from a Negative Hormone Response Element. Journal of Biological Chemistry.  ISSN 0021-9258.  277(51), s 49517- 49522 Vis sammendrag
  • Engedal, Nikolai; Korkmaz, Ceren & Saatcioglu, Fahri (2002). C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene.  ISSN 0950-9232.  21(7), s 1017- 1027 Vis sammendrag
  • Korkmaz, Kemal; Elbi, C.; Korkmaz, Ceren; Loda, M.; Hager, G. & Saatcioglu, Fahri (2002). Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. Journal of Biological Chemistry.  ISSN 0021-9258.  277(39), s 36689- 36696 Vis sammendrag
  • Thuestad, Gunnar; Berghagen, Hege; Ragnhildstveit, Erlend; Krogsrud, Kristin; Apriletti, James & Saatcioglu, Fahri (2002). Corepressor SMRT Functions as a Coactivator for Thyroid Hormone Receptor T3Ralpha from a Negative Hormone Response Element. Journal of Biological Chemistry.  ISSN 0021-9258.  277(51), s 49517- 49522
  • Yamamoto, Takeshi; Saatcioglu, Fahri & Matsuda, T. (2002). Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology.  ISSN 0013-7227.  143(7), s 2635- 2642 Vis sammendrag
  • Engedal, Nikolai; Korkmaz, Ceren & Saatcioglu, Fahri (2001). c-Jun N-terminal kinase is required for the induction of apoptosis in prostate cancer cells. Oncogene.  ISSN 0950-9232.  In Press
  • Korkmaz, Kemal; Korkmaz, Ceren; Ragnhildstveit, Erlend; Pretlow, T. G. & Saatcioglu, Fahri (2001). KLK4/KLK1/Prostase has a distinctly different gene structure compared with other members of the kallikrein family Alternative cDNA forms and regulation by multiple hormones. DNA and Cell Biology.  ISSN 1044-5498.  20, s 435- 445
  • Matsuda, T.; Junicho, A.; Yamamoto, Takeshi; Kishi, H.; Korkmaz, Kemal; Saatcioglu, Fahri; Fuse, H. & Muraguchi, A. (2001). Coss-talk between IL-6 and androgen receptor signaling in prostate carcinoma cells. Biochemical and Biophysical Research Communications - BBRC.  ISSN 0006-291X.  283, s 179- 187
  • Matsuda, T.; Yamamoto, Takeshi; Muraguchi, A. & Saatcioglu, Fahri (2001). Cross-talk between transforming growth factor-b and estrogen receptor signaling through Smad3. Journal of Biological Chemistry.  ISSN 0021-9258.  276, s 42908- 42914
  • Saatcioglu, Fahri & Engedal, Nikolai (2001). Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features. The Prostate.  ISSN 0270-4137.  46, s 289- 297
  • Slagsvold, Tore; Kraus, I.; Frønsdal, K. & Saatcioglu, Fahri (2001). A novel transcriptional function of the androgen receptor through triggering of coactivators. Journal of Biological Chemistry.  ISSN 0021-9258.  276, s 31030- 31036
  • Thompson, J.H.; Saatcioglu, Fahri; Jänne, O. A. & Palvimo, J. J. (2001). Discrupted Amino-and Carboxyl-terminal Interactions of the Androgen Receptor Are Linked to Androgen Insensitivity. Molecular Endocrinology.  ISSN 0888-8809.  15, s 923- 935
  • Saatcioglu, Fahri; Apriletti, J.; Thuestad, Gunnar & Kraus, I. (2000). The N-terminal domain of thyroid hormone receptor alpha is required for all of its biological activities. DNA and Cell Biology.  ISSN 1044-5498.  (19), s 389- 399
  • Saatcioglu, Fahri; Engedal, Nikolai & Frønsdal, K. (2000). Efficient methods for DNA-mediated gene transfer into prostate cancer cell line LNCaP. The Prostate.  ISSN 0270-4137.  (43), s 111- 117
  • Saatcioglu, Fahri; Junicho, A.; Matsuda, T.; Yamamoto, Takeshi; Kishi, H.; Korkmaz, Kemal; Fuse, H. & Muraguchi, A. (2000). Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Biochemical and Biophysical Research Communications - BBRC.  ISSN 0006-291X.  (278), s 9- 13
  • Saatcioglu, Fahri; Korkmaz, Kemal; Korkmaz, Ceren; Ragnhildstveit, Erlend & Pretlow, T. G. (2000). An Efficient procedure to clone hormone responsive genes from a specific tissue. DNA and Cell Biology.  ISSN 1044-5498.  (19), s 499- 506
  • Saatcioglu, Fahri; Korkmaz, Kemal; Korkmaz, Ceren; Ragnhildstveit, Erlend & Pretlow, T. G. (2000). Full-length cDNA sequence and genomic organization of human NKX3.1-Alternative forms and regulation by both androgens and estrogens. Gene.  ISSN 0378-1119.  (260), s 25- 36
  • Saatcioglu, Fahri; Slagsvold, Tore; Bentzen, Tore; Kraus, I. & Palvimo, J. J. (2000). Mutational analysis of the androgen receptor AF-2 core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors. Molecular Endocrinology.  ISSN 0888-8809.  (14), s 1603- 1617
  • Yamamoto, Takeshi; Matsuda, T.; Junicho, A.; Kishi, H.; Saatcioglu, Fahri & Muraguchi, A. (2000). Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Letters.  ISSN 0014-5793.  (486), s 143- 148

Se alle arbeider i Cristin

  • Storm, Margrethe; Kaarbo, Mari; Qu, Su; Wæhre, Haakon; Risberg, Bjørn Åke; Danielsen, Håkon & Saatcioglu, Fahri (2013). TCTP is Androgen-Regulated and Over-Expressed in Prostate Cancer. The FASEB Journal.  ISSN 0892-6638.  27
  • Tesikova, Martina; Dezitter, Xavier; Klokk, Tove Irene; Kirli, Zeynep; Hager, Gordon L. & Saatcioglu, Fahri (2011). Differential effects of histone deacetylase inhibitors on transcription factor dynamics and activity at the same response element. The FASEB Journal.  ISSN 0892-6638.  25
  • Lindstad, Torstein & Saatcioglu, Fahri (2007, 11. mai). Feit og frisk?. [Internett].  Forskning.no.
  • Lindstad, Torstein & Saatcioglu, Fahri (2007, 11. mai). Mus mot fedme.  Dagbladet. Vis sammendrag
  • Lorenzo, Petra Isabel O.; Arnoldussen, Yke Jildouw & Saatcioglu, Fahri (2007). Molecular mechanisms of apoptosis in prostate cancer. Critical reviews in oncogenesis.  ISSN 0893-9675.  13(1), s 1- 38
  • Davidson, Ben; Xi, Zhijun; Klokk, Tove Irene; Trope, Claes Gøran; Dørum, Anne; Scheistrøen, Marit & Saatcioglu, Fahri (2004). Expression of kallikrein 4 in epithelial ovarian carcinoma at different sites - evidence of divergent clinical role for tumor and stromal cells. Abstr. nr 128, s 451. Gynecologic Oncology.  ISSN 0090-8258.  92(1), s 393- 511
  • Lazarevic, B; Karlsen, Steinar; Kucuk, O & Saatcioglu, Fahri (2004). Genistein differentially regulates prostate-enriched protein expression in prostate cancer. Journal of Nutrition.  ISSN 0022-3166.  134, s 1258S- 1258S
  • Saatcioglu, Fahri (2004). Kallikrein 4 is a secreted protein - Response. Cancer Research.  ISSN 0008-5472.  64, s 8482- 8483
  • Xi, Zhijun; Klokk, Tove Irene & Saatcioglu, Fahri (2004). Expression of kallikrein 4 in epithelial ovarian carcinoma at different sites - evidence of divergent clinical role for tumor and stromal cells. Abstr 128.
  • Lazarevic, B; Karlsen, Steinar; Kucuk, O & Saatcioglu, Fahri (2003). Genistein differentially regulates prostate enriched protein expression in prostate cancer cells.
  • Thuestad, Gunnar; Kraus, Irene; Apriletti, James & Saatcioglu, Fahri (2000). DNA and Cell Biology The N-Terminal Domain of Thyroid Hormone Receptor-α Is Required for Its Biological Activities. ?.  19(7), s 389- 399

Se alle arbeider i Cristin

Publisert 4. nov. 2010 14:47 - Sist endret 7. juni 2016 15:31